Video

Improving the Safety of Diabetes Medications

Author(s):

As more diabetes drugs hit the market there are natural safety questions that come with these prescriptions. In recent years the US Food and Drug Administration has worked to increase the steps taken to ensure the safety of these drugs.

As more diabetes drugs hit the market there are natural safety questions that come with these prescriptions. In recent years the US Food and Drug Administration has worked to increase the steps taken to ensure the safety of these drugs.

Janet Woodcock, MD, director of the US Food and Drug Administration Center for Drug Evaluation and Research detailed some of the steps that have been taken to improve safety standards while not stopping the innovations needed to help current and future patients at The Endocrine Society's 97th Annual Meeting & Expo in San Diego.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
© 2024 MJH Life Sciences

All rights reserved.